Stanford Diabetes Research Center
斯坦福糖尿病研究中心
基本信息
- 批准号:9980396
- 负责人:
- 金额:$ 152.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAbbreviationsAmericanAppleAreaAwardAwarenessBasic ScienceBeta CellBiological AssayBiological SciencesBiomedical ResearchCaliforniaCardiovascular DiseasesCardiovascular systemCaringCellular biologyChemistryChild HealthChromatinClinicalClinical ResearchClinics and HospitalsCollaborationsCommunicationCommunitiesDevelopmentDiabetes MellitusDiabetes preventionDiagnosisDisciplineEducationEngineeringEnvironmentEventEvolutionFacultyFamilyFosteringFoundationsFundingFutureGeneticGenomicsGoalsGrowthHealthHealth PersonnelHeartHumanHumanitiesImmunologic MonitoringIndustrializationInstitutesInsulin-Dependent Diabetes MellitusInterdisciplinary StudyInternationalKidneyKidney DiseasesKnowledgeLeadershipLearningLettersMalignant neoplasm of pancreasMedicineMentorsMetabolismMissionModernizationNatural regenerationNon-Insulin-Dependent Diabetes MellitusObesityOccupationsPancreasPatientsPediatric HospitalsPhenotypePrincipal InvestigatorResearchResearch InstituteResearch PersonnelResearch SupportResearch TrainingResourcesRisk-TakingSan FranciscoSchoolsScienceScientistServicesSiliconStrategic PlanningSupervisionTechnologyTrainingTraining ProgramsTranslatingTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesWorkbasechimeric antigen receptor T cellschronic pancreatitisclinical careimprovedinnovationinsulin sensitivityisletmHealthmedical schoolsmembermultidisciplinarynext generationoutreachoutreach programprogramsranpirnaserecruitresearch clinical testingresearch studyscientific organizationstroke trials
项目摘要
Center overview abstract
The Stanford Diabetes Research Center (SDRC) embodies the culmination of a long-term strategic plan by the
Stanford University School of Medicine to create a premier program founded on a base of superb, collaborative
investigators studying basic, clinical and translational problems focused on improving diabetes care. Support of
this P30 application will leverage diabetes research at Stanford University by providing key resources
dedicated to supporting research, training and clinical activities focused on diabetes. Stanford has a well-
known tradition and reputation for academic excellence, scientific innovation, and clinical care, united in a true
University located on a single campus that facilitates and encourages interaction between scientists and
clinicians from different disciplines. Stanford is the heart of Silicon Valley, an epicenter of innovation and
calculated risk-taking, whose technology companies, start-ups, and mobile health companies partner with
SDRC faculty in unique and growing collaborations to advance diabetes research and care. The SDRC is
comprised of 94 investigators in 23 departments from the Schools of Medicine, Engineering, and Humanities &
Sciences. The SDRC mission is to foster innovation, new knowledge, and training in basic and translational
diabetes-related research, leading to improved diagnosis, treatment and prevention of diabetes and its
complications. The SDRC consists of: 1) Administrative Component that coordinates the scientific,
organizational, and outreach activities; 2) Biomedical Research Component that recruits and selects SDRC-
affiliated investigators and supervises the research cores that facilitate and enhance their research; 3) Pilot
and Feasibility Program that facilitates the development of new investigators into independent scientists and
encourages scientists in other fields to enter the field of diabetes research; and 4) Enrichment, Training, and
Outreach Program that fosters an environment conducive to collaborative, interdisciplinary research on
diabetes. NIH support for the SDRC is greatly amplified by: 1) Stanford's sustained commitment to provide
research space and additional financial resources; 2) a diverse, comprehensive array of research core services
at Stanford, which allows NIH funds to support unique, diabetes-related research cores; and 3) collaborative
efforts with other NIH-funded research centers at Stanford. The SDRC is evolving and dynamic, including
additions to its investigator base and research areas, expanded focus on clinical and translational research,
and evolution of core support to provide unique, indispensable core services devoted to diabetes research.
Because of the strategic plan to create a strong Stanford Diabetes Research Center, and the culture of
innovation this Center at Stanford creates, SCRC-affiliated investigators have made and are poised to continue
making important scientific contributions related to diabetes, obesity, and metabolism.
中心概况摘要
斯坦福糖尿病研究中心 (SDRC) 体现了斯坦福大学长期战略计划的巅峰
斯坦福大学医学院将创建一个以卓越、协作为基础的一流项目
研究基础、临床和转化问题的研究人员专注于改善糖尿病护理。支持
该 P30 应用程序将通过提供关键资源来利用斯坦福大学的糖尿病研究
致力于支持以糖尿病为重点的研究、培训和临床活动。斯坦福大学拥有良好的
以学术卓越、科学创新和临床护理而闻名的传统和声誉,团结在一个真正的
大学位于一个校园内,促进和鼓励科学家和科学家之间的互动
来自不同学科的临床医生。斯坦福大学是硅谷的心脏,是创新和发展的中心
有计划地承担风险,其技术公司、初创企业和移动医疗公司与他们合作
SDRC 教职人员开展独特且不断发展的合作,以推进糖尿病研究和护理。 SDRC 是
由来自医学院、工程学院和人文学院 23 个系的 94 名研究人员组成
科学。 SDRC 的使命是促进基础和转化领域的创新、新知识和培训
糖尿病相关研究,改善糖尿病及其相关疾病的诊断、治疗和预防
并发症。 SDRC 包括: 1) 行政部门,负责协调科学、
组织和外展活动; 2) 招募和选拔 SDRC 的生物医学研究部门-
附属研究人员并监督促进和加强其研究的研究核心; 3) 飞行员
可行性计划,促进新研究人员发展成为独立科学家和
鼓励其他领域的科学家进入糖尿病研究领域; 4) 丰富、培训和
外展计划营造有利于协作、跨学科研究的环境
糖尿病。 NIH 对 SDRC 的支持通过以下方式大大增强:1) 斯坦福大学持续致力于提供
研究空间和额外的财政资源; 2)多样化、全面的研究核心服务
斯坦福大学,允许 NIH 基金支持独特的糖尿病相关研究核心; 3)协作
与斯坦福大学其他 NIH 资助的研究中心合作。 SDRC 不断发展且充满活力,包括
扩大其研究者基础和研究领域,扩大对临床和转化研究的关注,
核心支持的演变,为糖尿病研究提供独特、不可或缺的核心服务。
由于创建强大的斯坦福糖尿病研究中心的战略计划,以及
斯坦福大学中心创造的创新,SCRC 附属研究人员已经做出并准备继续
在糖尿病、肥胖和新陈代谢方面做出了重要的科学贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Seung K Kim其他文献
A LexAop > UAS > QUAS trimeric plasmid to generate inducible and interconvertible Drosophila overexpression transgenes
LexAop->-UAS->-QUAS 三聚体质粒,用于生成可诱导和可相互转化的果蝇过表达转基因
- DOI:
10.1038/s41598-022-07852-7 - 发表时间:
2022-03-09 - 期刊:
- 影响因子:4.6
- 作者:
F. Wendler;Sangbin Park;Claire Hill;Alessia Galasso;Kathleen R Chang;Iman Awan;Y. Sudarikova;Mar Bustamante;Sichen Liu;E. Sung;Gabrielle Aisa;Seung K Kim;L. A. Baena - 通讯作者:
L. A. Baena
Seung K Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Seung K Kim', 18)}}的其他基金
In vivo systems to discover mechanisms regulating human islet alpha cell function
体内系统发现调节人类胰岛α细胞功能的机制
- 批准号:
10623306 - 财政年份:2020
- 资助金额:
$ 152.11万 - 项目类别:
In vivo systems to discover mechanisms regulating human islet alpha cell function
体内系统发现调节人类胰岛α细胞功能的机制
- 批准号:
10228762 - 财政年份:2020
- 资助金额:
$ 152.11万 - 项目类别:
In vivo systems to discover mechanisms regulating human islet alpha cell function
体内系统发现调节人类胰岛α细胞功能的机制
- 批准号:
10441477 - 财政年份:2020
- 资助金额:
$ 152.11万 - 项目类别:
相似海外基金
Renal Osteodystrophy Precision Medicine Project
肾性骨营养不良精准医疗项目
- 批准号:
10705266 - 财政年份:2022
- 资助金额:
$ 152.11万 - 项目类别:
Genome Center for Alzheimer's Disease (GCAD)
阿尔茨海默病基因组中心 (GCAD)
- 批准号:
10388085 - 财政年份:2016
- 资助金额:
$ 152.11万 - 项目类别:
Genome Center for Alzheimer's Disease (GCAD)
阿尔茨海默病基因组中心 (GCAD)
- 批准号:
10090891 - 财政年份:2016
- 资助金额:
$ 152.11万 - 项目类别: